Brief: Ryvu Therapeutics Q1 Net Loss Widens To 19.4 Mln Zlotys
May 15 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* Q1 NET LOSS AT 19.4 MILLION ZLOTYS VERSUS LOSS OF 17.6
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING REVENUE AT 25.4 MILLION ZLOTYS VERSUS 18.3
MILLION
ZLOTYS YEAR AGO
* Q1 OPERATING LOSS AT 22.5 MILLION ZLOTYS VERSUS LOSS OF
18.1
MILLION ZLOTYS YEAR AGO
Source text for Eikon: ID:nEM767HP0a
Further company coverage: RVU.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Q1 Net Loss 12.6 Million Zlotys
Brief: Ryvu Therapeutics Updates Romacyclib Development Strategy
Brief: Ryvu Therapeutics FY Net Loss At 101.2 Mln Zlotys
Brief: Ryvu Therapeutics Extends Research Collaboration And Exclusive License Agreement With BioNTech Until Nov 29, 2028
Brief: Ryvu Therapeutics Signs Grant Agreement With Poland's NCBR For PERO Project